본문 바로가기
KERD
논문KCI 등재

Noninvasive imaging biomarkers for liver fibrosis in nonalcoholic fatty liver disease: current and future

Han Ah Lee|김승업|Jung Hwan Yu
대한간학회 (The korean Association for the Study of the Liver)|2023.02|Clinical and Molecular Hepatology|제29권 제1호|pp. 136-149

2

조회

0

다운로드

8

인용

0

참고문헌

키워드

BiomarkersDiagnostic imagingLiver fibrosisNonalcoholic fatty liver disease

초록

Nonalcoholic fatty liver disease (NAFLD) is increasingly prevalent worldwide and becoming a major cause of liver disease-related morbidity and mortality. The presence of liver fibrosis in patients with NAFLD is closely related to prognosis, including the development of hepatocellular carcinoma and other complications of cirrhosis. Therefore, assessment of the presence of significant or advanced liver fibrosis is crucial. Although liver biopsy has been considered the “gold standard” method for evaluating the degree of liver fibrosis, it is not suitable for extensive use in all patients with NAFLD owing to its invasiveness and high cost. Therefore, noninvasive biochemical and imaging biomarkers have been developed to overcome the limitations of liver biopsy. Imaging biomarkers for the stratification of liver fibrosis have been evaluated in patients with NAFLD using different imaging techniques, such as transient elastography, shear wave elastography, and magnetic resonance elastography. Furthermore, artificial intelligence and deep learning methods are increasingly being applied to improve the diagnostic accuracy of imaging techniques and overcome the pitfalls of existing imaging biomarkers. In this review, we describe the usefulness and future prospects of noninvasive imaging biomarkers that have been studied and used to evaluate the degree of liver fibrosis in patients with NAFLD.

Abstract

Nonalcoholic fatty liver disease (NAFLD) is increasingly prevalent worldwide and becoming a major cause of liver disease-related morbidity and mortality. The presence of liver fibrosis in patients with NAFLD is closely related to prognosis, including the development of hepatocellular carcinoma and other complications of cirrhosis. Therefore, assessment of the presence of significant or advanced liver fibrosis is crucial. Although liver biopsy has been considered the “gold standard” method for evaluating the degree of liver fibrosis, it is not suitable for extensive use in all patients with NAFLD owing to its invasiveness and high cost. Therefore, noninvasive biochemical and imaging biomarkers have been developed to overcome the limitations of liver biopsy. Imaging biomarkers for the stratification of liver fibrosis have been evaluated in patients with NAFLD using different imaging techniques, such as transient elastography, shear wave elastography, and magnetic resonance elastography. Furthermore, artificial intelligence and deep learning methods are increasingly being applied to improve the diagnostic accuracy of imaging techniques and overcome the pitfalls of existing imaging biomarkers. In this review, we describe the usefulness and future prospects of noninvasive imaging biomarkers that have been studied and used to evaluate the degree of liver fibrosis in patients with NAFLD.

참고문헌 (80)

  1. 강성희, "KASL clinical practice guidelines: Management of nonalcoholic fatty liver disease", Clinical and Molecular Hepatology, 27(3), pp.363~401 (2021), 대한간학회
  2. Dulai PS, "Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease : systematic review and meta-analysis", Hepatology, 65, pp.1557~1565 (2017)
  3. Dae Won Jun, "An analysis of polygenic risk scores for non-alcoholic fatty liver disease", Clinical and Molecular Hepatology, 27(3), pp.446~447 (2021), 대한간학회[DOI]
  4. Hwi Young Kim, "Recent advances in nonalcoholic fatty liver disease metabolomics", Clinical and Molecular Hepatology, 27(4), pp.553~559 (2021), 대한간학회[DOI]
  5. Wijarnpreecha Karn, "Evaluation and Management of Extrahepatic Manifestations of Nonalcoholic Fatty Liver Disease", Clinical and Molecular Hepatology, 27(2), pp.221~235 (2021), 대한간학회[DOI]
  6. Taylor RS, "Association between fibrosis stage and outcomes of patients with nonalcoholic fatty liver disease : a systematic review and meta-analysis", Gastroenterology, 158, pp.1611~1625 (2020)
  7. Kanwal F, "Clinical care pathway for the risk stratification and management of patients with nonalcoholic fatty liver disease", Gastroenterology, 161, pp.1657~1669 (2021)
  8. Gwyneth Soon, "Updates in the quantitative assessment of liver fibrosis for nonalcoholic fatty liver disease: Histological perspective", Clinical and Molecular Hepatology, 27(1), pp.44~57 (2021), 대한간학회[DOI]
  9. European Association for the Study of the Liver, "EASL clinical practice guidelines on non-invasive tests for evaluation of liver disease severity and prognosis-2021 update", J Hepatol, 75, pp.659~689 (2021)
  10. Anstee QM, "Impact of non-invasive biomarkers on hepatology practice : past, present and future", J Hepatol, 76, pp.1362~1378 (2022)
  11. Dinani AM, "Application of artificial intelligence for diagnosis and risk stratification in NAFLD and NASH : the state of the art", Hepatology, 74, pp.2233~2240 (2021)
  12. Schawkat K, "Diagnostic accuracy of texture analysis and machine learning for quantification of liver fibrosis in MRI : correlation with MR elastography and histopathology", Eur Radiol, 30, pp.4675~4685 (2020)
  13. Nam D, "Artificial intelligence in liver diseases : Improving diagnostics, prognostics and response prediction", JHEP Rep, 4, pp.100443~ (2022)
  14. Loomba R, "Advances in non-invasive assessment of hepatic fibrosis", Gut, 69, pp.1343~1352 (2020)
  15. Yin M, "Ultrasound or MR elastography of liver:which one shall I use?", Abdom Radiol(NY), 43, pp.1546~1551 (2018)
  16. Siddiqui MS, "Vibration-controlled transient elastography to assess fibrosis and steatosis in patients with nonalcoholic fatty liver disease", Clin Gastroenterol Hepatol, 17, pp.156~163 (2019)
  17. de Lédinghen V, "Transient elastography(FibroScan)", Gastroenterol Clin Biol, 32(6 Suppl 1), pp.58~67 (2008)
  18. Lucidarme D, "Factors of accuracy of transient elastography(fibroscan)for the diagnosis of liver fibrosis in chronic hepatitis C", Hepatology, 49, pp.1083~1089 (2009)
  19. Jung KS, "Clinical applications of transient elastography", Clin Mol Hepatol, 18, pp.163~173 (2012)
  20. Wong VW, "Transient elastography", J Gastroenterol Hepatol, 25, pp.1726~1731 (2010)
  21. Lee HA, "Magnetic resonance imaging improves stratification of fibrosis and steatosis in patients with chronic liver disease", Abdom Radiol(NY), 47, pp.3733~3745 (2022)
  22. Eddowes PJ, "Accuracy of FibroScan controlled attenuation parameter and liver stiffness measurement in assessing steatosis and fibrosis in patients with nonalcoholic fatty liver disease", Gastroenterology, 156, pp.1717~1730 (2019)
  23. Cassinotto C, "Liver stiffness in nonalcoholic fatty liver disease : a comparison of supersonic shear imaging, FibroScan, and ARFI with liver biopsy", Hepatology, 63, pp.1817~1827 (2016)
  24. Park CC, "Magnetic resonance elastography vs transient elastography in detection of fibrosis and noninvasive measurement of steatosis in patients with biopsy-proven nonalcoholic fatty liver disease", Gastroenterology, 152, pp.598~607 (2017)
  25. Lee MS, "Prospective comparison among transient elastography, supersonic shear imaging, and ARFI imaging for predicting fibrosis in nonalcoholic fatty liver disease", PLoS One, 12, pp.e0188321~ (2017)
  26. Furlan A, "Comparison of 2D Shear wave elastography, transient elastography, and MR elastography for the diagnosis of fibrosis in patients with nonalcoholic fatty liver disease", AJR Am J Roentgenol, 214, pp.W20~W26 (2020)
  27. Imajo K, "Direct comparison of US and MR elastography for staging liver fibrosis in patients with nonalcoholic fatty liver disease", Clin Gastroenterol Hepatol, 20, pp.908~917 (2022)
  28. Shili-Masmoudi S, "Liver stiffness measurement predicts long-term survival and complications in non-alcoholic fatty liver disease", Liver Int, 40, pp.581~589 (2020)
  29. Petta S, "Monitoring occurrence of liver-related events and survival by transient elastography in patients with nonalcoholic fatty liver disease and compensated advanced chronic liver disease", Clin Gastroenterol Hepatol, 19, pp.806~815 (2021)
  30. Ferraioli G, "Accuracy of real-time shear wave elastography for assessing liver fibrosis in chronic hepatitis C : a pilot study", Hepatology, 56, pp.2125~2133 (2012)
  31. Friedrich-Rust M, "Performance of acoustic radiation force impulse imaging for the staging of liver fibrosis : a pooled meta-analysis", J Viral Hepat, 19, pp.e212~e219 (2012)
  32. Fraquelli M, "Liver stiffness measurement reliability and main determinants of point shear-wave elastography in patients with chronic liver disease", Aliment Pharmacol Ther, 44, pp.356~365 (2016)
  33. Nierhoff J, "The efficiency of acoustic radiation force impulse imaging for the staging of liver fibrosis : a meta-analysis", Eur Radiol, 23, pp.3040~3053 (2013)
  34. Myers RP, "Prevalence, risk factors and causes of discordance in fibrosis staging by transient elastography and liver biopsy", Liver Int, 30, pp.1471~1480 (2010)
  35. Bota S, "Intra-and interoperator reproducibility of acoustic radiation force impulse(ARFI)elastography--preliminary results", Ultrasound Med Biol, 38, pp.1103~1108 (2012)
  36. Argalia G, "Comparison of point shear wave elastography and transient elastography in the evaluation of patients with NAFLD", Radiol Med, 127, pp.571~576 (2022)
  37. Jiang W, "Diagnostic accuracy of point shear wave elastography and transient elastography for staging hepatic fibrosis in patients with non-alcoholic fatty liver disease : a meta-analysis", BMJ Open, 8, pp.e021787~ (2018)
  38. Barr RG, "Shear wave liver elastography", Abdom Radiol(NY), 43, pp.800~807 (2018)
  39. Lupșor-Platon M, "Noninvasive assessment of liver diseases using 2D shear wave elastography", J Gastrointestin Liver Dis, 25, pp.525~532 (2016)
  40. Karagiannakis DS, "Comparative utility of transient and 2D shear wave elastography for the assessment of liver fibrosis in clinical practice", J Digit Imaging, 34, pp.1342~1348 (2021)
  41. Ronot M, "Comparison of liver stiffness measurements by a 2D-shear wave technique and transient elastography : results from a European prospective multi-centre study", Eur Radiol, 31, pp.1578~1587 (2021)
  42. Kumada T, "Liver stiffness measurements by 2D shear-wave elastography : effect of steatosis on fibrosis evaluation", AJR Am J Roentgenol, 219, pp.604~612 (2022)
  43. Chimoriya R, "The use of two-dimensional shear wave elastography in people with obesity for the assessment of liver fibrosis in non-alcoholic fatty liver disease", J Clin Med, 10, pp.95~ (2020)
  44. Herrmann E, "Assessment of biopsy-proven liver fibrosis by two-dimensional shear wave elastography : an individual patient data-based meta-analysis", Hepatology, 67, pp.260~272 (2018)
  45. Idilman IS, "MR elastography of liver:current status and future perspectives", Abdom Radiol(NY), 45, pp.3444~3462 (2020)
  46. Guglielmo FF, "Liver MR elastography technique and image interpretation : pearls and pitfalls", Radiographics, 39, pp.1983~2002 (2019)
  47. Wagner M, "Technical failure of MR elastography examinations of the liver : experience from a large single-center study", Radiology, 284, pp.401~412 (2017)
  48. Singh S, "Diagnostic performance of magnetic resonance elastography in staging liver fibrosis : a systematic review and metaanalysis of individual participant data", Clin Gastroenterol Hepatol, 13, pp.440~451 (2015)
  49. Singh S, "Diagnostic accuracy of magnetic resonance elastography in liver transplant recipients : a pooled analysis", Ann Hepatol, 15, pp.363~376 (2016)
  50. Venkatesh SK, "Magnetic resonance elastography of liver in healthy Asians : normal liver stiffness quantification and reproducibility assessment", J Magn Reson Imaging, 39, pp.1~8 (2014)
  51. Shire NJ, "Test-retest repeatability of MR elastography for noninvasive liver fibrosis assessment in hepatitis C", J Magn Reson Imaging, 34, pp.947~955 (2011)
  52. Lee Yj, "MR elastography for noninvasive assessment of hepatic fibrosis : reproducibility of the examination and reproducibility and repeatability of the liver stiffness value measurement", J Magn Reson Imaging, 39, pp.326~331 (2014)
  53. Serai SD, "Repeatability of MR elastography of liver : a meta-analysis", Radiology, 285, pp.92~100 (2017)
  54. Yin M, "Assessment of hepatic fibrosis with magnetic resonance elastography", Clin Gastroenterol Hepatol, 5, pp.1207~1213 (2007)
  55. Singh S, "Magnetic resonance elastography for staging liver fibrosis in non-alcoholic fatty liver disease : a diagnostic accuracy systematic review and individual participant data pooled analysis", Eur Radiol, 26, pp.1431~1440 (2016)
  56. Cui J, "Magnetic resonance elastography is superior to acoustic radiation force impulse for the diagnosis of fibrosis in patients with biopsy-proven nonalcoholic fatty liver disease : a prospective study", Hepatology, 63, pp.453~461 (2016)
  57. Patel K, "Limitations of non-invasive tests for assessment of liver fibrosis", JHEP Rep, 2, pp.100067~ (2020)
  58. Xiao G, "Comparison of laboratory tests, ultrasound, or magnetic resonance elastography to detect fibrosis in patients with nonalcoholic fatty liver disease : a meta-analysis", Hepatology, 66, pp.1486~1501 (2017)
  59. Venkatesh SK, "Magnetic resonance elastography of liver : technique, analysis, and clinical applications", J Magn Reson Imaging, 37, pp.544~555 (2013)
  60. Kim D, "Advanced fibrosis in nonalcoholic fatty liver disease : noninvasive assessment with MR elastography", Radiology, 268, pp.411~419 (2013)
  61. Loomba R, "Magnetic resonance elastography predicts advanced fibrosis in patients with nonalcoholic fatty liver disease : a prospective study", Hepatology, 60, pp.1920~1928 (2014)
  62. Costa-Silva L, "MR elastography is effective for the non-invasive evaluation of fibrosis and necroinflammatory activity in patients with nonalcoholic fatty liver disease", Eur J Radiol, 98, pp.82~89 (2018)
  63. Loomba R, "Novel 3D magnetic resonance elastography for the noninvasive diagnosis of advanced fibrosis in NAFLD : a prospective study", Am J Gastroenterol, 111, pp.986~994 (2016)
  64. Hsu C, "Magnetic resonance vs transient elastography analysis of patients with nonalcoholic fatty liver disease : a systematic review and pooled analysis of individual participants", Clin Gastroenterol Hepatol, 17, pp.630~637 (2019)
  65. Wu WP, "Comparison of the efficacy of Gd-EOB-DTPA-enhanced magnetic resonance imaging and magnetic resonance elastography in the detection and staging of hepatic fibrosis", Medicine(Baltimore), 96, pp.e8339~ (2017)
  66. Wang QB, "Performance of magnetic resonance elastography and diffusion-weighted imaging for the staging of hepatic fibrosis : a meta-analysis", Hepatology, 56, pp.239~247 (2012)
  67. Ajmera V, "Liver stiffness on magnetic resonance elastography and the MEFIB index and liver-related outcomes in nonalcoholic fatty liver disease : a systematic review and meta-analysis of individual participants", Gastroenterology, 163, pp.1079~1089 (2022)
  68. Noureddin M, "MRI-based(MAST)score accurately identifies patients with NASH and significant fibrosis", J Hepatol, 76, pp.781~787 (2022)
  69. Kim BK, "Head-to-head comparison between MEFIB, MAST, and FAST for detecting stage 2 fibrosis or higher among patients with NAFLD", J Hepatol, 77, pp.1482~1490 (2022)
  70. Gidener T, "Liver stiffness by magnetic resonance elastography predicts future cirrhosis, decompensation, and death in NAFLD", Clin Gastroenterol Hepatol, 19, pp.1915~1924 (2021)
  71. Han MAT, "MR elastography-based liver fibrosis correlates with liver events in nonalcoholic fatty liver patients : a multicenter study", Liver Int, 40, pp.2242~2251 (2020)
  72. Tamaki N, "Liver fibrosis and fatty liver as independent risk factors for cardiovascular disease", J Gastroenterol Hepatol, 36, pp.2960~2966 (2021)
  73. Yin Z, "Prediction of nonalcoholic fatty liver disease(NAFLD)activity score(NAS)with multiparametric hepatic magnetic resonance imaging and elastography", Eur Radiol, 29, pp.5823~5831 (2019)
  74. Cunha GM, "Automated CNN-based analysis versus manual analysis for mr elastography in nonalcoholic fatty liver disease : intermethod agreement and fibrosis stage discriminative performance", AJR Am J Roentgenol, 219, pp.224~232 (2022)
  75. Stafylidou M, "Performance of Baveno VI and expanded Baveno VI criteria for excluding high-risk varices in patients with chronic liver diseases : a systematic review and meta-analysis", Clin Gastroenterol Hepatol, 17, pp.1744~1755 (2019)
  76. Petta S, "Non-invasive prediction of esophageal varices by stiffness and platelet in non-alcoholic fatty liver disease cirrhosis", J Hepatol, 69, pp.878~885 (2018)
  77. Zeng J, "Dynamic changes in liver stiffness measured by transient elastography predict clinical outcomes among patients with chronic hepatitis B", J Ultrasound Med, 36, pp.261~268 (2017)
  78. Elsharkawy A, "Changes in liver stiffness measurements and fibrosis scores following sofosbuvir based treatment regimens without interferon", J Gastroenterol Hepatol, 32, pp.1624~1630 (2017)
  79. Ajmera VH, "Clinical utility of an increase in magnetic resonance elastography in predicting fibrosis progression in nonalcoholic fatty liver disease", Hepatology, 71, pp.849~860 (2020)
  80. Gidener T, "Change in serial liver stiffness measurement by magnetic resonance elastography and outcomes in NAFLD", Hepatology, 77, pp.268~274 (2023)

관련 논문AI추천

Non-invasive imaging biomarkers for liver steatosis in non-alcoholic fatty liver disease: present and futureAsako Nogami, Atsushi Nakajima, Kento Imajo, Masato Yoneda, Michihiro Iwaki, Satoru Saito, Takashi Kobayashi, Yasushi Honda, Yuji Ogawa대한간학회 · Clinical and Molecular Hepatology2023 · 제29권 제2호Role of noninvasive tests in the prognostication of metabolic dysfunction-associated steatotic liver diseaseGrace Lai-Hung Wong, Jimmy Che-To Lai, Sherlot Juan Song, Terry Cheuk-Fung Yip, Vincent Wai-Sun Wong, Yichong Jiang, Yue Wang대한간학회 · Clinical and Molecular Hepatology2025 · 제31권 제2호Advanced Imaging Techniques for Assessing Fat, Iron, and Fibrosis in Chronic Liver DiseaseFranca Manuela, Idilman Ilkay S., Narayanasamy Sabarish, Venkatesh Sudhakar K., Yin Meng거트앤리버 소화기연관학회협의회 · Gut and Liver2025 · 제19권 제1호Magnetic Resonance Elastography and Other Magnetic Resonance Imaging Techniques in Chronic Liver Disease: Current Status and Future DirectionsCher Heng Tan, Sudhakar Kundapur Venkatesh거트앤리버 소화기연관학회협의회 · Gut and Liver2016 · 제10권 제5호Surveillance of the progression and assessment of treatment endpoints for nonalcoholic steatohepatitisJian-Gao Fan, Yi-Wen Shi대한간학회 · Clinical and Molecular Hepatology2023 · 제29권 제1호Non-invasive imaging biomarkers for liver steato- sis in non-alcoholic fatty liver disease: present and futureLynna Alnimer, Mazen Noureddin대한간학회 · Clinical and Molecular Hepatology2023 · 제29권 제2호

이 간행물의 다른 논문 (46건)

Subclinical versus advanced forms of alcohol-related liver disease: Need for early detectionLuma Melo, David Martí-Aguado, Ramón Bataller, Concepción Gómez-Medinapp. 1-15PrefaceYoon Jun Kimpp. 2-2PrefaceSeung Up Kimpp. 3-3Non-alcoholic fatty liver disease: Definition and subtypesSeul Ki Han, 김문영, 백순구pp. 5-16Management of refractory ascitesFlorence Wongpp. 16-32
원문 보기